The Wistar Institute and Man's Best Friend Therapeutics Announce Partnership to Advance Canine Melanoma Cancer Vaccine
Thursday, November 17, 2016 - 13:01
in Health & Medicine
The Wistar Institute and Man's Best Friend Therapeutics are pleased to announce a new collaboration that leverages Wistar's groundbreaking vaccine research and development with MBFT's expertise in developing animal health products.